Abstract Number: 1960 • 2016 ACR/ARHP Annual Meeting
2015 ACR/ARHP Workforce Study in the U.S.: The Role of Graduate Medical Education (GME) in Adult Rheumatology
2015 ACR/ARHP Workforce Study in the U.S.: The Role of Graduate Medical Education (GME) in Adult Rheumatology Background/Purpose: The 2015 ACR/ARHP Workforce Study provides a…Abstract Number: 1961 • 2016 ACR/ARHP Annual Meeting
Identification of Novel Genetic Susceptibility Loci in Primary Antiphospholipid Syndrome
Background/Purpose: Antiphospholipid syndrome (APS) is an autoimmune disease with incompletely understood etiology, characterized by recurrent thrombosis and pregnancy complications. We conducted this study to understand…Abstract Number: 1962 • 2016 ACR/ARHP Annual Meeting
Antiphospholipid Syndrome Neutrophils Are Characterized By Overexpression of P-Selectin Glycoprotein Ligand 1, a Potential Therapeutic Target
Background/Purpose: Treatment of the thrombotic manifestations of antiphospholipid syndrome (APS) primarily focuses on inhibiting clotting pathways. In an effort to identify upstream inflammatory targets that…Abstract Number: 1963 • 2016 ACR/ARHP Annual Meeting
Thrombospondin-1 Is Elevated in the Plasma of Patients with Antiphospholipid Syndrome and Is Correlated with Free Active TGF-b1 Levels, IL-1b and IL-17A
Background/Purpose: Antiphospholipid syndrome (APS) is an acquired thombophillia characterized by recurrent thromboembolism and pregnancy morbidity. Thrombospondin (TSP-1) is a matricellular glycoprotein secreted by platelets upon…Abstract Number: 1964 • 2016 ACR/ARHP Annual Meeting
The Frequency and Clinical Significance of IgA Anticardiolipin and Anti-β2-Glycoprotein-I Antibodies in Antiphospholipid Antibody Patients with and without Lupus
Background/Purpose: APS ACTION International Clinical Database and Repository was created to study the natural course of disease over 10 years in persistently antiphospholipid antibody (aPL)-positive…Abstract Number: 1965 • 2016 ACR/ARHP Annual Meeting
Antiphospholipid Syndrome Alliance for Clinical Trials & International Networking Registry Analysis: First and Recurrent Thrombosis Risk after 720 Patient-Years of Follow-up
Background/Purpose: APS ACTION Registry was created to study the natural course of disease over 10 years in persistently antiphospholipid antibody (aPL)-positive patients. Previously, based on…Abstract Number: 1966 • 2016 ACR/ARHP Annual Meeting
Antibodies Against Domain 1 and Domain 4/5 of β2 Glycoprotein I: Clinical Relevance in Obstetric Anti-Phospholipid Syndrome
Background/Purpose: The domain reactivity of antibodies against b2 glycoprotein I (anti-b2GPI) has been investigated in patients with thrombotic anti-phospholipid syndrome (APS), leading to the identification…Abstract Number: 1967 • 2016 ACR/ARHP Annual Meeting
Depression Is a Risk Factor for Low Treatment Adherence in African American People with Systemic Lupus Erythematosus
Background/Purpose: African American (AA) people with Systemic Lupus Erythematosus (SLE) are at high risk for severe disease and depression, and often require complex medication regimes.…Abstract Number: 1968 • 2016 ACR/ARHP Annual Meeting
Adverse Childhood Experiences and Outcomes of Systemic Lupus Erythematosus
Background/Purpose: Adverse childhood experiences such as extreme deprivation, neglect, abuse, parental separation or incarceration, have been associated with adult health status, including onset of rheumatic…Abstract Number: 1969 • 2016 ACR/ARHP Annual Meeting
Peer Approaches to Lupus Self-Management (PALS): A Novel Lupus Peer Mentorship Intervention
Background/Purpose: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that is associated with increased morbidity, mortality, health care costs and decreased quality of life.…Abstract Number: 1970 • 2016 ACR/ARHP Annual Meeting
Disparities in Access to Specialist Care at the Time of Diagnosis of Systemic Lupus Erythematosus
Background/Purpose: Disparities in outcomes among racial/ethnic minorities and individuals with low socioeconomic status with systemic lupus erythematosus (SLE) have been well reported. The degree to…Abstract Number: 1971 • 2016 ACR/ARHP Annual Meeting
Predictors of Delays to Care and Associated Outcomes in Pediatric Lupus Patients from the Childhood Arthritis and Rheumatology Research Alliance Registry
Background/Purpose: CARRA registry data for participants meeting ACR classification criteria for lupus were analyzed. Delays of one month, 3 months, and one year from symptom…Abstract Number: 1972 • 2016 ACR/ARHP Annual Meeting
Creatine Kinase in the United States Population: Impact of Demographics, Comorbidities and Body Composition on the Normal Range
Background/Purpose: The accurate interpretation of creatine kinase (CK) values is critical as this laboratory measure guides the workup of suspected myopathies. Incidentally discovered CK elevation…Abstract Number: 1973 • 2016 ACR/ARHP Annual Meeting
Intramuscular Versus Ultrasound Guided Peritendinous Glucocorticoid Injection for Tenosynovitis in Patients with Rheumatoid Arthritis – a Randomised, Double-Blind, Controlled Study
Background/Purpose: The aim of this study was to compare the efficacy of intramuscular versus ultrasound (US)-guided peritendinous glucocorticoid injection in providing disease control after…Abstract Number: 1974 • 2016 ACR/ARHP Annual Meeting
Is Ultrasound of the Hands Enough to Reveal Ongoing Subclinical Inflammation in Rheumatoid Arthritis Patients in Clinical Remission According to Composite Scores?
Background/Purpose: Several studies have shown the presence of subclinical inflammation by ultrasound (US) in rheumatoid arthritis (RA) patients despite clinical remission according to clinical composite…
ACR Meeting Abstracts